Suchergebnisse - "Follmann, Dean"

PubPharm (43)

1

A note on familywise error rate for a primary and secondary endpoint

enthalten in: Biometrics | 2023

von Proschan, M. | Follmann, D.

2

Discussion on "estimating vaccine efficacy over time after a randomized study is unblinded" by Anastasios A. Tsiatis and Marie Davidian

enthalten in: Biometrics | 2022

von Follmann, D.

CommentOn: Biometrics. 2022 Sep;78(3):825-838. - PMID 34174097

3

A unified evaluation of differential vaccine efficacy

enthalten in: Biometrics | 2020

von Gabriel, E. | Sachs, M. | Follmann, D. | +1

4

A unified evaluation of differential vaccine efficacy

enthalten in: Biometrics | 2020

von Gabriel, E. | Sachs, M. | Follmann, D. | +1

5

Sieve analysis using the number of infecting pathogens

enthalten in: Biometrics | 2018

von Follmann, D. | Huang, C.

6

Incorporating founder virus information in vaccine field trials

enthalten in: Biometrics | 2015

von Follmann, D. | Huang, C.

7

Incorporating Founder Virus Information in Vaccine Field Trials

in: Biometrics | 2015

von Follmann, D. | Huang, C.

8

Incorporating founder virus information in vaccine field trials

enthalten in: Biometrics | 2015

von Follmann, D. | Huang, C.

9

An augmented probit model for missing predictable covariates in quantal bioassay with small sample size

enthalten in: Biometrics | 2011

von Follmann, D. | Nason, M.

10

An Augmented Probit Model for Missing Predictable Covariates in Quantal Bioassay with Small Sample Size

in: Biometrics | 2011

von Follmann, D. | Nason, M.

1
2
3
4
5
Nächster »
[5]